Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Journal Scan / Research · July 26, 2021

Pyrotinib Treatment in Patients With HER2+ Metastatic Breast Cancer and Brain Metastasis

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Pyrotinib Treatment in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
Clin. Cancer Res 2021 Jun 10;[EPub Ahead of Print], M Anwar, Q Chen, D Ouyang, S Wang, N Xie, Q Ouyang, P Fan, L Qian, G Chen, E Zhou, L Guo, X Gu, B Ding, X Yang, L Liu, C Deng, Z Xiao, J Li, Y Wang, S Zeng, J Hu, W Zhou, B Qiu, Z Wang, J Weng, M Liu, Y Li, T Tang, J Wang, H Zhang, B Dai, W Tang, T Wu, M Xiao, X Li, H Liu, L Li, W Yi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading